Candriam SCA’s Redhill Biopharma RDHL Stock Holding History

Candriam SCA’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-71	Closed	-$180K	–	816
2022 Q1	$180K	Hold	71	–	–	﹤0.01%	778
2021 Q4	$184K	Sell	71 -12	-14%	-$48K	﹤0.01%	788
2021 Q3	$378K	Hold	83	–	–	﹤0.01%	796
2021 Q2	$568K	Hold	83	–	–	﹤0.01%	788
2021 Q1	$637K	Hold	83	–	–	0.01%	694
2020 Q4	$663K	Hold	83	–	–	0.01%	706
2020 Q3	$843K	Hold	83	–	–	0.01%	638
2020 Q2	$553K	Buy	83 +12	+17%	+$82.6K	0.01%	696
2020 Q1	$424K	Hold	71	–	–	﹤0.01%	723
2019 Q4	$433K	Hold	71	–	–	﹤0.01%	741
2019 Q3	$502K	Hold	71	–	–	0.01%	686
2019 Q2	$461K	Hold	71	–	–	0.01%	744
2019 Q1	$592K	Hold	71	–	–	0.01%	694
2018 Q4	$395K	Hold	71	–	–	0.01%	719
2018 Q3	$629K	Hold	71	–	–	0.01%	684
2018 Q2	$608K	Hold	71	–	–	0.01%	675
2018 Q1	$367K	Hold	71	–	–	0.01%	709
2017 Q4	$368K	Hold	71	–	–	0.01%	706
2017 Q3	$770K	Hold	71	–	–	0.01%	608
2017 Q2	$619K	Hold	71	–	–	0.01%	639
2017 Q1	$683K	Hold	71	–	–	0.01%	615
2016 Q4	$745K	Hold	71	–	–	0.02%	560
2016 Q3	$992K	Hold	71	–	–	0.02%	498
2016 Q2	$778K	Hold	71	–	–	0.02%	485
2016 Q1	$868K	Hold	71	–	–	0.02%	454
2015 Q4	$914K	Hold	71	–	–	0.02%	396
2015 Q3	$920K	Hold	71	–	–	0.02%	445
2015 Q2	$1.25M	Hold	71	–	–	0.03%	416
2015 Q1	$1.04M	Hold	71	–	–	0.02%	450
2014 Q4	$945K	Buy	+71	New	+$736K	0.02%	444

Other funds holding RDHL

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Candriam SCA's RDHL Position: Q2 2022 in Review

Candriam SCA sold out of Redhill Biopharma (RDHL) in Q2 2022, closing a stake of 71 shares — an estimated $180K sold.

Candriam SCA first reported a position in RDHL in Q4 2014 and held it in 30 quarters. The position peaked at $1.25M in Q2 2015. 44 funds tracked by Wall St. Rank hold RDHL as of Q2 2022.

Candriam SCA reported no remaining Redhill Biopharma position as of Q2 2022 after selling out during the quarter.
Candriam SCA sold 71 Redhill Biopharma shares in Q2 2022, an estimated $180K.
Candriam SCA first reported a position in Redhill Biopharma in Q4 2014 and held it in 30 quarters.
Candriam SCA's Redhill Biopharma position peaked at $1.25M in Q2 2015.
44 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.